JPS61145111A - Production of tablet - Google Patents
Production of tabletInfo
- Publication number
- JPS61145111A JPS61145111A JP26877984A JP26877984A JPS61145111A JP S61145111 A JPS61145111 A JP S61145111A JP 26877984 A JP26877984 A JP 26877984A JP 26877984 A JP26877984 A JP 26877984A JP S61145111 A JPS61145111 A JP S61145111A
- Authority
- JP
- Japan
- Prior art keywords
- powder
- tablet
- coated
- water
- tablets
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Glanulating (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
(57)【要約】本公報は電子出願前の出願データであるた
め要約のデータは記録されません。(57) [Summary] This bulletin contains application data before electronic filing, so abstract data is not recorded.
Description
【発明の詳細な説明】
産業上の利用分野
本発明は、乾式直接打錠法により錠剤を製造する方法に
関し、更に詳述すると、錠剤材料中に成型性の劣る粉末
が含まれている場合でも打錠性がよく、圧縮成型性、硬
度等の特性に優れた錠剤を得ることができる方法に関す
る。DETAILED DESCRIPTION OF THE INVENTION Field of Industrial Application The present invention relates to a method for manufacturing tablets by a dry direct compression method. The present invention relates to a method for obtaining tablets that have good compressibility and excellent properties such as compression moldability and hardness.
従来の技術及びその問題点
従来、アセトアミノフェン粉末、アスコルビン酸粉末等
の成型性の劣る粉末を含む錠剤材料を用いて乾式直接打
錠法により錠剤を製造する場合、錠剤の圧縮成型性を高
めるためにポリエチレングリコール、ゼラチン、デキス
トリン、セルロース等の結合剤の微粉末を錠剤原料に混
合することが知られている(特公昭45−15755号
)。また、成型性の劣る粉末の成型性を高めるため、微
結晶化したセルロースを更に極微粉化し、これを成型性
の劣る粉末と練合して該粉末に展延コーティングするこ
とも提案されている(特公昭46−8718号)。Conventional techniques and their problems Conventionally, when tablets are manufactured by a dry direct compression method using tablet materials containing powders with poor moldability such as acetaminophen powder and ascorbic acid powder, it is necessary to improve the compression moldability of the tablets. For this purpose, it is known to mix fine powder of a binder such as polyethylene glycol, gelatin, dextrin, cellulose, etc. with the tablet raw material (Japanese Patent Publication No. 15755/1983). Additionally, in order to improve the moldability of powders with poor moldability, it has also been proposed to further pulverize microcrystalline cellulose, knead it with powder with poor moldability, and apply spread coating to the powder. (Special Publication No. 46-8718).
しかしながら、前者の方法は、結合剤微粉末を多量に使
用する必要があり、従って製造工程やコスト、品質等の
点で不利が生じるという問題がある。また、後者の方法
は、セルロース極微粉の粉末へのコーティングが均一と
なり難く、従って得られた錠剤の品質にばらつきが生じ
るという問題がある。However, the former method requires the use of a large amount of fine binder powder, resulting in disadvantages in terms of manufacturing process, cost, quality, etc. In addition, the latter method has the problem that it is difficult to uniformly coat the ultrafine cellulose powder, resulting in variations in the quality of the obtained tablets.
発明の概要
本発明者らは、上記事情に鑑み、成型性の劣る粉末の成
型性を高めることにつき種々検討を行なっているうち、
1〜15%(重:fiit%、以下同じ)濃度の水溶性
高分子物質水溶液を粉末打錠成分の1種又は2種以上の
表面に上記水溶性高分子物質量がコーティングすべき粉
末打錠成分量の0.1〜5%となるようにスプレーコー
ティングし、これを乾燥することにより、結合剤として
の水溶性高分子物質を少量しか用いない場合でも粉末打
錠成分表面に水溶性高分子物質が均一にコーティングさ
れ、成型性に優れた水溶性高分子物質コーティング粉末
が得られると共に、このコーティング粉末を錠剤材料に
混合し、これを乾式直接打錠法によって打錠した場合、
打錠性がよく、圧縮成型性、硬度等の特性に優れた錠剤
を得ることができることを知見し、本発明をなすに至っ
たものである。Summary of the Invention In view of the above circumstances, the present inventors have conducted various studies on improving the moldability of powders with poor moldability.
A powder tablet in which the surface of one or more of the powder tablet components is coated with an aqueous solution of a water-soluble polymer substance having a concentration of 1 to 15% (weight: fiit%, the same hereinafter) with the above amount of water-soluble polymer substance. By spray coating the coating to a concentration of 0.1 to 5% of the ingredient amount and drying it, even if only a small amount of water-soluble polymer material is used as a binder, the water-soluble polymer material can be coated on the surface of the powdered tablet ingredients. When a water-soluble polymer substance coated powder is obtained which is uniformly coated with a substance and has excellent moldability, and this coated powder is mixed with tablet material and tableted by a dry direct compression method,
The present invention was based on the discovery that it is possible to obtain tablets with good compressibility, excellent properties such as compression moldability and hardness.
以下、本発明につき更に詳しく説明する。The present invention will be explained in more detail below.
発明の構成
本発明に係る錠剤の製造方法は、1〜15%濃度の水溶
性高分子物質水溶液を粉末打錠成分の1種又は2種以上
の表面に上記水溶性高分子物質量がコーティングすべき
粉末打錠成分量の0.1〜5チとなるようにスプレーコ
ーティングし、これを乾燥して水溶性高分子物質コーテ
ィング粉末を得ると共に、このコーティング粉末を混合
した錠剤原料を乾式直接打錠法によシ打錠して錠剤を得
るものである。Structure of the Invention The method for manufacturing a tablet according to the present invention comprises coating the surface of one or more types of powder tableting components with an aqueous solution of a water-soluble polymer substance having a concentration of 1 to 15%. Spray coating is applied to the desired amount of powder tableting ingredients to be 0.1 to 5%, and this is dried to obtain a water-soluble polymer coated powder, and the tablet raw material mixed with this coating powder is dry-directly compressed into tablets. Tablets are obtained by compression according to the law.
この場合、水溶性高分子物質の種類に制限はなく、例え
ばゼラチン、ペクチン、ポリアクリル酸、ポリアクリル
酸塩、ポリビニルアルコール、ポリビニルピロリドン、
ポリビニルピロリドン−ビニルアセテート共重合体、?
リエチレンオキサイド、カルブキシメチルセルロースナ
トリウム、ヒドロキシプロピルセルロース、メチルセル
ロース、エチルセルロース、アルギン酸塩、キサンタン
ガム、アラビアガム、トラガカントガム、カラヤガム、
カラダナン、メチルビニルエーテル・無水マレイン酸共
重合体等の合成、半合成及び天然水溶性高分子物質から
選ばれる1種又は2種以上を用いることができるが、本
発明においてはポリビニルピコリドン、ヒドロキシプロ
ピルセルロース、メチルセルロース、アラビアガム及び
カラダナンの1種又は2種以上を使用することが特に好
ましい。In this case, there are no restrictions on the type of water-soluble polymeric substance, such as gelatin, pectin, polyacrylic acid, polyacrylate, polyvinyl alcohol, polyvinylpyrrolidone,
Polyvinylpyrrolidone-vinyl acetate copolymer,?
Liethylene oxide, sodium carboxymethylcellulose, hydroxypropylcellulose, methylcellulose, ethylcellulose, alginate, xanthan gum, gum arabic, gum tragacanth, gum karaya,
One or more types selected from synthetic, semi-synthetic, and natural water-soluble polymer substances such as caradanan, methyl vinyl ether/maleic anhydride copolymer, etc. can be used, but in the present invention, polyvinylpicolidone, hydroxypropyl It is particularly preferred to use one or more of cellulose, methylcellulose, gum arabic and caradanan.
また、上記水溶性高分子物質の水溶液は、上述したよう
に水溶性高分子物質の濃度を1〜15チとすることが必
要であり、濃度が1チよシ低いとスプレ一時間及び乾燥
時間が長時間必要となシ、製造効率が低下すると共に、
コストも高くなる。In addition, as mentioned above, the aqueous solution of the water-soluble polymeric substance needs to have a concentration of 1 to 15%, and if the concentration is lower than 1%, it will take one hour to spray and dry. It takes a long time, which reduces manufacturing efficiency and
The cost will also be higher.
また、濃度が10%より高いと水溶液の粘度が高くなり
、スプレー圧を高くする必要が生じ、しかも粉末表面に
均一にコーティングすることが困難になり、かつ二次凝
集が発生するのでこれを粉砕する工程が必要となり、従
って製造工程が複雑になると共に、均一な品質の錠剤を
得ることが困難になる。なお、水溶性高分子物質のよシ
好ましい濃度は1〜5%である。In addition, if the concentration is higher than 10%, the viscosity of the aqueous solution will increase, making it necessary to increase the spray pressure, making it difficult to coat the powder surface uniformly, and secondary agglomeration may occur, so it must be ground. Therefore, the manufacturing process becomes complicated and it becomes difficult to obtain tablets of uniform quality. Note that the most preferable concentration of the water-soluble polymeric substance is 1 to 5%.
本発明は上述した水溶性高分子物質の水溶液を粉末打錠
成分の1種又は2種以上にスプレーし、この打錠成分の
表面に水溶性高分子物質をコーティングするものである
が、コーティングは成型性の劣る粉末打錠成分に対して
行なうことが好ましい。このような成分としては、アセ
トアミノフェン、アスコルビン酸等が挙げられる。この
場合、これらの成分の2種以上を錠剤材料とするときは
、その1種のみに対してコーティングするようにしても
よく、2種以上に対してコーティングを行なってもよい
。なお、これらコーティングすべき粉末成分の平均粒度
は150μ〜840μとすることが好ましい。In the present invention, an aqueous solution of the water-soluble polymeric substance described above is sprayed onto one or more powder tableting ingredients, and the surface of the tabletting ingredients is coated with the water-soluble polymeric substance. It is preferable to carry out this method for powdered tablet components that have poor moldability. Such ingredients include acetaminophen, ascorbic acid, and the like. In this case, when two or more of these components are used as tablet material, only one of these components may be coated, or two or more of these components may be coated. In addition, it is preferable that the average particle size of these powder components to be coated is 150μ to 840μ.
コーティングすべき粉末打錠成分表面への水溶性高分子
物質のコーテイング量は、上述したようにコーティング
すべき成分に対し0.1〜5%とすることが必要であシ
、コーテイング量が0.1%より少ないと粉末の成型性
が改善されず、また5%より多いと錠剤の崩壊性が悪く
なり、多量の崩壊剤が必要となるため、コストが高くな
る。なお、コーテイング量のよシ好ましい範囲は1〜3
%である。The coating amount of the water-soluble polymer substance on the surface of the powder tablet component to be coated needs to be 0.1 to 5% of the component to be coated, as described above, and the coating amount is 0.1% to 5% of the component to be coated. If it is less than 1%, the moldability of the powder will not be improved, and if it is more than 5%, the disintegration properties of the tablet will be poor and a large amount of disintegrant will be required, resulting in high costs. The coating amount is preferably in the range of 1 to 3.
%.
なお、粉末打錠成分に水溶性高分子物質水溶液をスプレ
ーし、これを乾燥する方法、条件に制限はなく、公知の
方法、条件を採用できる。There are no restrictions on the method and conditions for spraying the water-soluble polymer substance aqueous solution onto the powder tablet component and drying it, and known methods and conditions can be employed.
本発明においては、上記水溶性高分子物質をコーティン
グした粉末を他の錠剤材料と混合し、これを用いて通常
の装置、方法によシ乾式直接打錠法で錠剤を製造するも
のである。In the present invention, the powder coated with the above-mentioned water-soluble polymer substance is mixed with other tablet materials, and tablets are manufactured using the powder by a dry direct compression method using conventional equipment and methods.
この場合、錠剤材料の他の成分に限定はなく、賦形剤、
崩壊剤、滑沢剤、有効成分等を適宜配合できる。In this case, there are no limitations on the other ingredients of the tablet material, including excipients,
Disintegrants, lubricants, active ingredients, etc. can be added as appropriate.
発明の詳細
な説明したように、本発明に係る錠剤の製造方法によれ
ば、錠剤材料中に成型性の劣る粉末打錠成分が含まれて
いても、粉末打錠成分の1種又は2糧以上の表面に水溶
性高分子物質を被覆したことによシその成型性が向上し
、従って打錠性に優れ、圧縮成型性、硬度等の良好な特
性を有する錠剤を得ることができる。しかも、本発明に
よれば、水溶性高分子物質(結合剤)を少量しか使用し
ない場合でも粉末打錠成分光面に均一に水溶性高分子物
質をコーティングできるため、多量の結合剤使用に併な
うコスト高、コーティングの不均一性に併なう錠剤品質
のばらつきといった問題が生じない。As described in detail of the invention, according to the method for manufacturing tablets according to the present invention, even if the tablet material contains powder tableting components with poor formability, one or both of the powder tableting components can be used. By coating the above surface with a water-soluble polymeric substance, the moldability is improved, and therefore, tablets can be obtained that have excellent tabletting properties and good properties such as compression moldability and hardness. Moreover, according to the present invention, even if only a small amount of water-soluble polymer substance (binder) is used, the light surface of the powder tablet component can be uniformly coated with the water-soluble polymer substance. Problems such as high costs and variations in tablet quality due to non-uniformity of coating do not occur.
次に実施例及び比較例を示し、本発明を具体的に説明す
る。Next, examples and comparative examples will be shown to specifically explain the present invention.
〔実施例1〜5、比較例1〜5〕
容量51の流動層造粒機に3に9のアセトアミノフェン
粉末を入れ、これに第1表に示す濃度でヒドロキシプロ
ピルセルロース(RPC)klA!O水に溶解した水溶
液を吸気温度70℃、排気温度50℃の条件でそれぞれ
スプレーコーティングし、ヒドロキシプロピルセルロー
スがコーチインつてれた各7セトアミノフエン粉末A−
E(本発明品)ヲ得り。なお、ヒドロキシプロピルセル
ロースのアセトアミノ7エン)粉末へのコーテイング量
は第1衣に示す通シである。[Examples 1 to 5, Comparative Examples 1 to 5] Three to nine parts of acetaminophen powder was placed in a fluidized bed granulator with a capacity of 51, and hydroxypropylcellulose (RPC) klA! was added at the concentration shown in Table 1. Each 7 cetaminophene powder A- coated with hydroxypropyl cellulose was spray coated with an aqueous solution dissolved in O water at an intake temperature of 70°C and an exhaust temperature of 50°C.
E (product of the present invention) obtained. Note that the amount of hydroxypropyl cellulose coated on the acetamin 7ene powder is as shown in the first coating.
第1表
次に、上記粉末A−Eをそれぞれ下記成分と均一に混合
して各錠剤材料を得た後、この材料を乾式直接打錠法に
よシ打錠して実施例1〜50錠剤を製造し、これら錠剤
の硬度及びキャッピング率専記方法で調べた。また、比
較のためアセトアミノ7エン粉末ニヒドロキシプロピル
セルロースをコーティングせず、アセトアミノフェン粉
末に対して第2表に示す混合量でヒドロキシプロピルセ
ルロース粉末を単に混合する以外は実施例1〜5と同様
の方法でそれぞれ比較例1〜5の錠剤を製造し、同様に
錠剤硬度及びキャッピング率を調べた。更ニ、ヒドロキ
シプロピルセルロースをアセトアミノフェン粉末にコー
ティングせず、またこれを混合しない対照例の錠剤を同
様に製造し、同様の測定を行なった。結果を第2表に示
すつ成分
アセトアミノフェノン+ヒドロキシプロピルセルロース
29.3 %アスピリン
47.9#カフエイン
11.5#ステアリン酸マグネシウム 0
.21計
100゜0I(1)硬度二錠剤破壊強度測定機
(2)キャッピング率二錠剤磨損度試験機、10個、5
分間第2表
第2表の結果よシ、アセトアミノフェン粉末にヒドロキ
シプロピルセルロースをコーチインクシたものを配合し
た実施例の錠剤は、いずれも硬度が適度でかつキャッピ
ングが生じ難いことが認めラレタ。これに対し、粉末ヒ
ドロキシプロピルセルロースを単に配合したものはすべ
てがキャッピングし、しかも打錠成型時に欠は等の障害
を起こした。また、成型性が悪いため適当な硬度の錠剤
は得られなかった。Table 1 Next, each of the above powders A to E was uniformly mixed with the following components to obtain each tablet material, and then this material was compressed by a dry direct tableting method to give Examples 1 to 50 tablets. The hardness and capping rate of these tablets were investigated using a proprietary method. In addition, for comparison, the same procedure as Examples 1 to 5 was performed except that the acetaminophen powder was not coated with the dihydroxypropyl cellulose powder and the hydroxypropyl cellulose powder was simply mixed with the acetaminophen powder in the amount shown in Table 2. Tablets of Comparative Examples 1 to 5 were manufactured using the method described above, and the tablet hardness and capping rate were similarly examined. Furthermore, control tablets in which hydroxypropyl cellulose was not coated or mixed with acetaminophen powder were prepared in the same manner, and the same measurements were performed. The results are shown in Table 2. Two components: Acetaminophenone + Hydroxypropylcellulose 29.3% Aspirin
47.9# Caffeine
11.5# Magnesium stearate 0
.. 21 total
100゜0I (1) Hardness 2 tablet breaking strength measuring machine (2) Capping rate 2 tablet abrasion tester, 10 pieces, 5
According to the results in Table 2, it was found that the tablets of the examples containing acetaminophen powder coated with hydroxypropyl cellulose had moderate hardness and were unlikely to cause capping. . On the other hand, all of the tablets containing powdered hydroxypropylcellulose were capped, and problems such as chipping occurred during tablet compression. Furthermore, due to poor moldability, tablets with appropriate hardness could not be obtained.
〔実施例6〕
容t5J?の流動層造粒機に3kgのアセトアミノフェ
ン粉末を入れ、これに6011のヒドロキシプロピルセ
ルロースを1ノの水に溶解した水溶液(ヒドロキシプロ
ピルセルロース濃度6%)全吸気温度70℃、排気温度
50℃の条件でスプレーコーティングし、アセトアミノ
フェンの重量に対して2チのヒドロキシプロピルセルロ
ースをコーティングした粉末を得た。[Example 6] Volume t5J? Put 3 kg of acetaminophen powder into a fluidized bed granulator, and add to it an aqueous solution of 6011 hydroxypropyl cellulose dissolved in 1 ml of water (hydroxypropyl cellulose concentration 6%), total intake temperature 70°C, exhaust temperature 50°C. Spray coating was carried out under the following conditions to obtain a powder coated with 2 parts of hydroxypropylcellulose per weight of acetaminophen.
次に、上記粉末1.53時、アスピリン2.5 kg、
カフェイン0.6 kg、スターチ等の賦形剤o、55
kg及びステアリン酸マグネシウム0.01kgを均一
に混合して錠剤材料を得た後、この材料を乾式直接打錠
法によシ打錠して錠剤を製造した。Next, at 1.53 hours of the above powder, 2.5 kg of aspirin,
Caffeine 0.6 kg, excipients such as starch o, 55
After uniformly mixing 0.01 kg of magnesium stearate to obtain a tablet material, this material was compressed by a dry direct tableting method to produce tablets.
〔実施例7〕
容量3ノの流動層造粒機に1.5 kgのアスコルビン
酸粉末を入れ、これに759のポリビニルピロリドンを
675−の水に溶解した水溶液(ポリビニルピロリドン
濃度1os)を吸気温度55℃、排気温度45℃の条件
でスプレーコーティングし、アスコルビン酸の重量に対
して5%のポリビニルピロリドンをコーティングした粉
末を得た。[Example 7] 1.5 kg of ascorbic acid powder was placed in a fluidized bed granulator with a capacity of 3 mm, and an aqueous solution of 759 polyvinylpyrrolidone dissolved in 675 mm water (polyvinylpyrrolidone concentration 1 os) was added to the inlet air temperature. Spray coating was carried out under conditions of 55° C. and exhaust temperature of 45° C. to obtain a powder coated with 5% polyvinylpyrrolidone based on the weight of ascorbic acid.
上記粉末0.85に9.アビセル0.1に9.コーンス
ターチ0.045kp及びタルク0.005k19を均
一に混合して錠剤材料を得た後、この材料を乾式直接打
錠法によシ打錠して錠剤を製造した。9. to 0.85 of the above powder. Avicel 0.1 to 9. A tablet material was obtained by uniformly mixing 0.045 kp of corn starch and 0.005 k19 of talc, and then this material was compressed by a dry direct compression method to produce tablets.
上記実施例6,7の錠剤は、いずれも圧縮成型性に優れ
、かつ硬度が適度なものであった。The tablets of Examples 6 and 7 had excellent compression moldability and moderate hardness.
Claims (1)
末打錠成分の1種又は2種以上の表面に上記水溶性高分
子物質量がコーティングすべき粉末打錠成分量の0.1
〜5重量%となるようにスプレーコーティングし、これ
を乾燥して水溶性高分子物質コーティング粉末を得ると
共に、このコーティング粉末を混合した錠剤材料を乾式
直接打錠法により打錠して錠剤を得ることを特徴とする
錠剤の製造方法。1. An aqueous solution of a water-soluble polymeric substance having a concentration of 1 to 15% by weight is coated on the surface of one or more types of powder tableting ingredients by 0.1 of the amount of the powder tableting ingredients to be coated with the above-mentioned amount of water-soluble polymeric substance.
Spray coat to ~5% by weight, dry this to obtain a water-soluble polymer coated powder, and tablet material mixed with this coating powder is compressed using a dry direct compression method to obtain tablets. A method for manufacturing a tablet, characterized by:
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP26877984A JPS61145111A (en) | 1984-12-20 | 1984-12-20 | Production of tablet |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP26877984A JPS61145111A (en) | 1984-12-20 | 1984-12-20 | Production of tablet |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS61145111A true JPS61145111A (en) | 1986-07-02 |
| JPH0587487B2 JPH0587487B2 (en) | 1993-12-16 |
Family
ID=17463170
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP26877984A Granted JPS61145111A (en) | 1984-12-20 | 1984-12-20 | Production of tablet |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS61145111A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0587383A1 (en) * | 1992-09-10 | 1994-03-16 | Halliburton Company | A method of making a cement agglomeration. |
| JP2012175977A (en) * | 2005-05-18 | 2012-09-13 | Dsm Ip Assets Bv | Composition for administering microorganism into intestine |
| WO2017195796A1 (en) * | 2016-05-10 | 2017-11-16 | 日本臓器製薬株式会社 | Method for manufacturing acetaminophen preparation |
| JP2019182758A (en) * | 2018-04-04 | 2019-10-24 | アリメント工業株式会社 | Capping suppression coating powder and table including the same |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5759803A (en) * | 1980-09-30 | 1982-04-10 | Takeda Chem Ind Ltd | Granule of l-sodium ascorbate, its preparation, and tablet comprising it |
| JPS57130913A (en) * | 1980-12-22 | 1982-08-13 | Monsanto Co | Direct compress analgesic drug granulating composition, tablets thereof and manufacture |
-
1984
- 1984-12-20 JP JP26877984A patent/JPS61145111A/en active Granted
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5759803A (en) * | 1980-09-30 | 1982-04-10 | Takeda Chem Ind Ltd | Granule of l-sodium ascorbate, its preparation, and tablet comprising it |
| JPS57130913A (en) * | 1980-12-22 | 1982-08-13 | Monsanto Co | Direct compress analgesic drug granulating composition, tablets thereof and manufacture |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0587383A1 (en) * | 1992-09-10 | 1994-03-16 | Halliburton Company | A method of making a cement agglomeration. |
| US5454867A (en) * | 1992-09-10 | 1995-10-03 | Halliburton Company | Cement agglomeration |
| JP2012175977A (en) * | 2005-05-18 | 2012-09-13 | Dsm Ip Assets Bv | Composition for administering microorganism into intestine |
| WO2017195796A1 (en) * | 2016-05-10 | 2017-11-16 | 日本臓器製薬株式会社 | Method for manufacturing acetaminophen preparation |
| JP6310164B1 (en) * | 2016-05-10 | 2018-04-11 | 日本臓器製薬株式会社 | Method for producing acetaminophen preparation |
| JP2018090638A (en) * | 2016-05-10 | 2018-06-14 | 日本臓器製薬株式会社 | Method for producing acetaminophen preparation |
| CN109069455A (en) * | 2016-05-10 | 2018-12-21 | 日本脏器制药株式会社 | The manufacturing method of Aceta Elixir |
| US11033501B2 (en) | 2016-05-10 | 2021-06-15 | Nippon Zoki Pharmaceutical Co., Ltd. | Method for manufacturing acetaminophen preparation |
| US11433031B2 (en) | 2016-05-10 | 2022-09-06 | Nippon Zoki Pharmaceutical Co., Ltd. | Method for manufacturing acetaminophen preparation |
| JP2019182758A (en) * | 2018-04-04 | 2019-10-24 | アリメント工業株式会社 | Capping suppression coating powder and table including the same |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0587487B2 (en) | 1993-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5006345A (en) | Direct tableting auxiliary | |
| KR930008951B1 (en) | Method for preparing vitamin-containing granules | |
| KR890004685B1 (en) | Sustained Release Composition | |
| EP0361874B1 (en) | Granules having core and their production | |
| US4036948A (en) | L-ascorbic acid tablets | |
| KR920000737B1 (en) | Substained release compositions comprising hydroxy propyl cellulose ethers | |
| CA1244768A (en) | Sugar and starch free spray-dried vitamin c powder containing 90 percent ascorbic acid | |
| EP0487774B1 (en) | A direct tabletting auxiliary | |
| EP2674149B1 (en) | Method of preparing composite granule comprising low-substituted hydroxypropyl cellulose and rapid release preparation | |
| US4702919A (en) | Granules of thiamine salt and the production thereof | |
| EP0456720B1 (en) | High ibuprofen content granulations | |
| EP3308774B1 (en) | Hydroxyalkyl alkyl cellulose, method for producing the same, and solid preparation | |
| EP0436373B1 (en) | Process for making tablets containing spray-dried naproxen or naproxen sodium | |
| CA2494716A1 (en) | Pharmaceutical preparation containing a benzimidazole compound mixed with microcrystalline cellulose and a method for its preparation | |
| US5470580A (en) | Directly-compressible naproxen or naproxen sodium compositions | |
| WO2023108895A1 (en) | Telmisartan oral solid preparation with stable product performance, and preparation method therefor | |
| JPH0774153B2 (en) | Loxoprofen / sodium-containing preparation | |
| JPS61145111A (en) | Production of tablet | |
| JP2001114703A (en) | Solid preparation and production method thereof | |
| JP2003116966A (en) | Formulation of direct tableting formulation and adjuvant | |
| JP2711528B2 (en) | Loxoprofen preparation | |
| KR100358614B1 (en) | Production method of fuocide | |
| US5534551A (en) | Aminoguanidine spray drying process | |
| KR0134089B1 (en) | Enteric film and manufacturing method thereof | |
| CN118634198A (en) | A kind of hydroxychloroquine sulfate tablet and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| LAPS | Cancellation because of no payment of annual fees |